Nektar Therapeutics Non-Current Portion of LTD and Capital Lease Obligation (Annual) Insights

Nektar Therapeutics (NKTR)

37.09 +0.56 (+1.53%) USD | NASDAQ | Jan 23, 16:00

37.09 0.00 (0.00%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for NKTR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

Start Trial

Rigel Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade
Eli Lilly & Co.	Upgrade
Ironwood Pharmaceuticals, Inc.	Upgrade
Lyell Immunopharma, Inc.	Upgrade